Literature DB >> 10928293

Renal endothelin-1 is linked to changes in urinary salt and volume in essential hypertension. Salt Sensitivity Group of the Italian Society of Hypertension.

L S Malatino1, I Bellanuova, A Cataliotti, F Cuzzola, F Mallamaci, G Tripepi, S Parlongo, S Cutrupi, R A Mangiafico, C Ferri, F Galletti, N Glorioso, P Strazzullo, C Zoccali.   

Abstract

METHODS: We investigated the influence of salt intake on urinary and plasma endothelin-1 (ET-1) in 55 patients who entered a two-week double-blind, randomised, crossover study comparing a 50 mMol/day salt intake and 150 mMol/day. Twenty-four-hour ET-1 excretion and plasma ET-1 were measured by RIA on pre-extracted samples.
RESULTS: In the whole cohort (n=55), changes in urinary ET-1 were related to salt excretion (r=0.28, P=0.04) and urinary volume (r=0.47, P=0.0001). In a multivariable model, changes in PRA, plasma aldosterone, blood pressure and heart rate did not add any predictive power to salt excretion with regard to urinary ET-1 variations. The relationship between urinary volume and urinary ET-1 was stronger than that of urinary sodium with ET-1 excretion because sodium was excluded from the multivariable model when urinary volume was introduced. Changes in urinary ET-1 were unrelated to mean blood pressure changes (P=0.66). Changes in plasma ET-1 were unaffected by changes in salt intake (P=0.58) but were strongly related to those in PRA (r= -0.45, P=0.01) and plasma aldosterone (r= -0.53, P=0.002).
CONCLUSIONS: The renal excretion of ET-1 is influenced by changes in salt intake and appears largely independent of the blood pressure response to salt. Changes in urinary volume which accompany variations in salt excretion play an important role in this response. Since urinary ET-1 reflects its renal synthesis, our data support the notion that renal ET-1 plays a role in the regulation of sodium balance in patients with mild hypertension.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10928293

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  8 in total

Review 1.  The future of endothelin-receptor antagonism as treatment for systemic hypertension.

Authors:  Gabriel Vorobiof; Burns C Blaxall; John D Bisognano
Journal:  Curr Hypertens Rep       Date:  2006-04       Impact factor: 5.369

Review 2.  Physiology of endothelin and the kidney.

Authors:  Donald E Kohan; Edward W Inscho; Donald Wesson; David M Pollock
Journal:  Compr Physiol       Date:  2011-04       Impact factor: 9.090

Review 3.  Regulation of blood pressure and salt homeostasis by endothelin.

Authors:  Donald E Kohan; Noreen F Rossi; Edward W Inscho; David M Pollock
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

4.  Flow regulation of endothelin-1 production in the inner medullary collecting duct.

Authors:  Meghana M Pandit; Edward W Inscho; Shali Zhang; Tsugio Seki; Rajeev Rohatgi; Luca Gusella; Bellamkonda Kishore; Donald E Kohan
Journal:  Am J Physiol Renal Physiol       Date:  2015-01-13

5.  Flow regulation of collecting duct endothelin-1 production.

Authors:  Brianna Lyon-Roberts; Kevin A Strait; Evan van Peursem; Wararat Kittikulsuth; Jennifer S Pollock; David M Pollock; Donald E Kohan
Journal:  Am J Physiol Renal Physiol       Date:  2010-12-22

6.  Na delivery and ENaC mediate flow regulation of collecting duct endothelin-1 production.

Authors:  Meghana M Pandit; Kevin A Strait; Toshio Matsuda; Donald E Kohan
Journal:  Am J Physiol Renal Physiol       Date:  2012-02-22

Review 7.  Role of collecting duct endothelin in control of renal function and blood pressure.

Authors:  Donald E Kohan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-08-28       Impact factor: 3.619

8.  Characterization of flow-regulated cortical collecting duct endothelin-1 production.

Authors:  Nirupama Ramkumar; Yang Gao; Donald E Kohan
Journal:  Physiol Rep       Date:  2017-02-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.